VIRAZOLE

This brand name is authorized in Canada, New Zealand, United States

Active ingredients

The drug VIRAZOLE contains one active pharmaceutical ingredient (API):

1 Ribavirin UNII 49717AWG6K - RIBAVIRIN

Ribavirin is a synthetic nucleoside analogue which has shown in vitro activity against some RNA and DNA viruses. The mechanism by which ribavirin in combination with other medicinal products exerts its effects against HCV is unknown. Read about Ribavirin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VIRAZOLE Inhalation solution	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AP01		J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AP Antivirals for treatment of HCV infections
Discover more medicines within J05AP01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02170140
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 4101
Country: US	FDA, National Drug Code	Identifier(s): 0187-0007